BTSG BrightSpring Health Services, Inc.
Services-Home Health Care Services · Nasdaq · SEC CIK 1865782 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY26.0%
TTM net income YoY216.6%
TTM EPS YoY204.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin12.5%
Operating margin3.4%
Net margin2.7%
FCF margin3.2%
EBITDA margin4.5%
Returns
ROE20.5%
ROA6.7%
ROIC (approx.)11.0%
Asset turnover2.48x
Leverage & solvency
Liabilities / assets65.1%
Debt / equity1.00x
Current ratio1.62x
Interest coverage3.59x
Cash quality & payout
Operating cash flow / net income1.47x
Accruals ratio-3.1%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4.21B | $3.87B | $3.61B | $3.55B | $3.33B | $3.15B | $2.88B | $2.75B |
| Gross profit | $518.55M | $492.75M | $482.22M | $412.55M | $392.01M | $374.85M | $338.37M | $338.67M |
| SG&A expense | $358.07M | $362.36M | $360.77M | $304.44M | $304.17M | $326.30M | $287.63M | $283.13M |
| Operating income | $160.48M | $130.39M | $121.45M | $108.11M | $87.84M | $48.56M | $50.74M | $55.54M |
| Interest expense | $31.04M | $36.88M | $38.62M | $38.53M | $38.23M | $38.78M | $41.76M | $46.18M |
| Pretax income | $129.44M | $93.51M | $82.83M | $69.58M | $49.61M | $9.78M | $8.98M | $9.36M |
| Income tax | $28.64M | $6.91M | $8.55M | $20.03M | $12.12M | $1.24M | -$240,000 | $5.08M |
| Net income | $100.14M | $84.29M | $148.77M | $77.08M | $55.84M | $28.21M | $29.54M | $16.00M |
| EBITDA | $198.85M | $171.81M | $160.54M | $147.64M | $128.60M | $90.40M | $92.90M | $110.42M |
| EPS (basic) | 0.48 | 0.41 | 0.73 | — | 0.27 | 0.14 | 0.15 | — |
| EPS (diluted) | 0.45 | 0.38 | 0.67 | — | 0.26 | 0.13 | 0.14 | — |
| Weighted avg. shares (diluted) | 220.23M | 220.28M | 221.32M | — | 217.98M | 216.34M | 214.93M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $717.84M | $550.38M | $888.80M | $88.37M | $140.34M | $70.07M | $52.34M | $60.95M |
| Receivables | $1.22B | $1.14B | $1.11B | $989.72M | $1.01B | $972.72M | $975.26M | $902.78M |
| Inventory | $671.59M | $575.01M | $560.17M | $815.18M | $639.20M | $625.47M | $533.64M | $636.56M |
| Current assets | $2.77B | $2.47B | $2.69B | $2.89B | $2.78B | $2.65B | $2.53B | $1.89B |
| PP&E, net | $213.53M | $213.87M | $201.88M | $204.69M | $175.49M | $177.58M | $177.23M | $180.57M |
| Goodwill | $2.54B | $2.54B | $2.53B | $2.55B | $2.37B | $2.37B | $2.37B | $2.36B |
| Intangibles | $491.66M | $514.42M | $536.88M | $557.55M | $521.61M | $544.34M | $568.28M | $595.22M |
| Total assets | $6.27B | $5.99B | $6.21B | $6.41B | $6.05B | $5.94B | $5.85B | $5.93B |
| Current liabilities | $1.71B | $1.56B | $1.55B | $1.85B | $1.55B | $1.51B | $1.46B | $1.43B |
| Short-term debt | $35.28M | $41.45M | $52.96M | $52.34M | $51.87M | $50.84M | $48.73M | $48.73M |
| Long-term debt | $2.15B | $2.15B | $2.44B | $2.46B | $2.47B | $2.48B | $2.49B | $2.56B |
| Total debt | $2.18B | $2.19B | $2.50B | $2.51B | $2.52B | $2.53B | $2.54B | $2.61B |
| Total liabilities | $4.08B | $3.93B | $4.22B | $4.53B | $4.23B | $4.20B | $4.16B | $4.27B |
| Shareholders' equity | $2.18B | $2.05B | $1.98B | $1.88B | $1.82B | $1.74B | $1.69B | $1.65B |
| Net debt | $1.46B | $1.64B | $1.61B | $2.42B | $2.38B | $2.46B | $2.49B | $2.55B |
| Shares outstanding | 198.81M | 197.51M | 193.21M | 192.12M | 180.69M | 177.06M | 175.18M | 174.25M |
| Cash flow statement | ||||||||
| Operating cash flow | $204.32M | $43.92M | $122.94M | $231.56M | $107.94M | $49.08M | $101.60M | $90.61M |
| Capital expenditure | $22.09M | $29.03M | $21.54M | $37.66M | $15.76M | $24.43M | $17.63M | $15.31M |
| Free cash flow | $182.23M | $14.88M | $101.40M | $193.89M | $92.17M | $24.65M | $83.97M | $75.30M |
| Investing cash flow | -$23.19M | -$28.20M | $747.39M | -$233.88M | -$23.76M | -$23.24M | -$24.19M | -$15.78M |
| Financing cash flow | -$13.67M | -$354.13M | -$70.02M | -$50.50M | -$13.11M | -$8.24M | -$86.02M | -$49.55M |
| Depreciation & amortization | $38.37M | $41.42M | $39.09M | $39.52M | $40.75M | $41.84M | $42.16M | $54.88M |
| Stock-based compensation | $17.87M | $19.49M | $3.68M | $14.37M | $17.25M | $22.80M | $15.68M | $13.98M |
| Share buybacks | $0 | $60.00M | $60.00M | — | — | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 15 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.